Successful North American Product Launch Prompts SAW Instruments GmbH to Extend sam®X Early Adopter Price Promotion  
12/15/2011 9:30:58 AM

Bonn, Germany – 15th December 2011: SAW Instruments, developer of the innovative sam® family of biosensors for real-time, label-free assays using living cells, has extended the price promotion surrounding the launch of its new sam®X biosensor. The promotion was so successfully received at the recent North American launch of the product (held at the IBC Antibody Engineering and Antibody Therapeutics meeting in San Diego) that SAW Instruments has decided to make the offer available across Europe and North America. If ordered before the end of 2011, the new system can be obtained at a special early adopter price.

As the high-end member of the sam® family of acoustic biosensors, the new sam®X is designed to offer even greater workflow flexibility and high-throughput capability when analysing molecular interactions on the surface of living mammalian cells. Using Surface Acoustic Wave (SAW) technology, the sam® systems represent an evolution in the way such interactions are measured, producing accurate data much faster than can be achieved using similar equilibrium based approaches.

To find out more about the current sam®X price promotion, contact Ian Taylor ( before the end of the year, or for more information on the sam® family visit the SAW Instruments website at

Notes on the technology

Surface Acoustic Wave technology is based on the ability of a wave of energy to travel across the surface of a material. Each surface has a typical inherent elasticity affecting the way the energy of the wave dissipates as it travels across the surface of the material being analysed. Thus, the nature of the surface in question, and therefore any changes to it, can be assessed by sensors monitoring the behaviour of the wave as it propagates across the surface. In particular, changes in mass result in alterations to the phase of the wave, whilst viscoelastic and conformational characteristics influence wave amplitude. The technology developed and employed by SAW instruments is capable of accurately interpreting this information in order to provide real time readouts measuring binding and conformational changes in the samples through which the wave passes.

About SAW Instruments GmbH

SAW Instruments GmbH designs, develops and sells biosensor-based laboratory instruments for life sciences research. The proprietary technology of SAW Instruments employs a Surface Acoustic Waves approach to biological measurement, rather than using traditional optical methods such as SPR. The technology is uniquely positioned compared to other biosensor technologies based on its ability to measure conformational changes in cells, membranes and vesicles. In addition, the system is also capable of providing other industry standard measurements including those involving kinetics, quantitation and affinity.

SAW instruments has more than ten years experience in the field of label-free biosensor technology and a number of our customers have successfully published work employing the platform. It is our goal is to continue to build on this experience, as well as to develop a family of workflow-driven products to further meet our customers’ needs.